Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (2657)	10/19/2000 12:30:19 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

I would venture to guess that I understand financial analysis much better than you, mad2. You have been spouting the same nonsense about price to sales going on two years now. During that time, Gum Tech's sales have increased quarter to quarter every quarter and the price to sales ratio has gone down while the stock remains in a long term uptrend. Stock prices discount the future, and the roe/roa based on last year's data doesn't mean squat. To do a discounted cash flow analysis, you have to make projections about future cash flows. I have yet to see any projections from you.